0920-1335 Acknowledgement by a Cruise Ship Operator In Lieu of a S

Phased Approach to the Resumption of Cruise Ship Passenger Operations

Attachment W_ Acknowledgment In Lieu of a Simulated Voyage

Cruise Ship Operator - Acknowledgement by a Cruise Ship Operator in lieu of a Simulated Voyage (if applicable)

OMB: 0920-1335

Document [pdf]
Download: pdf | pdf
The President and Chief Executive Officer of the operating cruise company, the Chief Ethics
and/or Compliance Officer of the operating cruise company and all parent companies, and the
highest-ranking Medical Officer of the operating cruise company and all parent companies must
sign the following acknowledgement:
ACKNOWLEDGEMENT BY A CRUISE SHIP OPERATOR
IN LIEU OF A SIMULATED VOYAGE

I do hereby certify that the following conditions are true and correct to the best of my knowledge
and belief for _________________________________:
•

Restricted passenger voyages will only operate with 95% 1 of crew who are
fully vaccinated. 2

•

A clear and specific vaccination plan and timeline to limit cruise ship sailings
to 95% of passengers who will be confirmed as fully vaccinated prior to
sailing has been submitted to CDC.

I understand that this acknowledgement is being submitted to the CDC in lieu of
__________________________________________ conducting a simulated voyage under the
CDC’s Framework for Conditional Sailing Order.
_______________________________________________

________________

Signature Official 1
____________________________________________________
Name and Title

Date

_______________________________________________

________________

Signature Official 2
____________________________________________________
Name and Title

Date

_______________________________________________

________________

Signature Official 3
____________________________________________________
Name and Title

Date

1
2

This excludes any newly embarking crew in quarantine.
Fully Vaccinated Against COVID-19[3] means it has been:
• 2 weeks (14 days) or more since a person received a second dose of an accepted 2-dose series COVID-19
vaccine; OR
• 2 weeks (14 days) or more since a person received a dose of an accepted single-dose COVID-19 vaccine; OR
• 2 weeks (14 days) or more since the person received a vaccine or combination of vaccines listed in CDC’s
Interim Public Health Recommendations for Fully Vaccinated People.

_______________________________________________

________________

Signature Official 4
____________________________________________________
Name and Title

Date

_______________________________________________

________________

Signature Official 5
____________________________________________________
Name and Title

Date

_______________________________________________

________________

Signature Official 6
____________________________________________________
Name and Title

Date


File Typeapplication/pdf
AuthorWhite, Stefanie B. (CDC/DDID/NCEZID/DGMQ)
File Modified2021-10-27
File Created2021-10-17

© 2024 OMB.report | Privacy Policy